TikTok Content Creators Fueling Unofficial Trade for Unlicensed Slimming Drug

A shadow market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are urged to message these profiles directly for supplier links, while also receiving discount codes.

Active Commerce on Messaging Platforms

Separately, a robust trade exists on Telegram, where communities with thousands of members share comparison photos, administration instructions and claims of rapid UK delivery. Sellers market the substance there before directing customers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Experts Voice Concerns

However, doctors and pharmacists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could result in individuals administering substances of uncertain source.

Some experts said the demand for retatrutide could be linked to the increasing price of licensed weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Some influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach pharmaceutical, advertising, and customer laws, risking penalties, legal action or imprisonment.

Platform Reaction and Content Elimination

According to the social media company, the platform has taken down violative material and banned related hashtags and search suggestions. The organization stated it was committed to maintaining the service safe and allocating resources in strengthening enforcement strategies.

Online Trading Operations

Investigations also found communities with up to 9,000 participants selling retatrutide using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, filled with images of weight loss, positive testimonials and step-by-step guides for preparing or administering at residence.

Within moments of joining one group, a vendor shared WhatsApp details, where most purchases occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about body mass, health issues or previous experience.

Product Details and Pricing

Inside these communities, messages display dark colored packages with postal service labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with sterile water, or ready-to-use injectors usually priced at £160 for 20mg. When questioned how much time a injector should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for the messaging service stated it actively monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting materials they can’t verify. Even if the science behind this drug is sound, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake injections are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has already encountered patients harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company investigational product not yet approved … may expose users to potentially serious health risks”.